Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Translational Lung Cancer Research|January 9, 2026
Radiotherapy <i>vs</i>. photodynamic therapy: a comparison of antitumor effects and pulmonary toxicity in preclinical modelsYoshihisa Hiraishi, Takamasa Koga, Hiroyuki Ogawa, et al.
The Annals of Thoracic Surgery|June 25, 2025
Intraoperative Surgical Margin Assessment of Sublobar Lung Resection Specimens Using Computed TomographyShinsuke Kitazawa, Nicholas Bernards, Yuki Sata, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 11, 2023
Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinomaUlf Zeuge, Aline F Fares, Joelle Soriano, et al.
The Oncologist|July 24, 2024
Outcomes in older adults with metastatic esophageal and gastric carcinoma treated with palliative chemotherapyXin Wang, Michael J Allen, Osvaldo Espin-Garcia, et al.
The Oncologist|November 15, 2022
Comparison of Four Clinical Prognostic Scores in Patients with Advanced Gastric and Esophageal CancerLucy X Ma, Osvaldo Espin-Garcia, Yvonne Bach, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 9, 2026
Utility of computed tomography-based intraoperative surgical margin evaluation in wedge resected lung specimensTakahiro Yanagihara, Kentaro Miura, Nicholas Bernards, et al.
Science Advances|March 21, 2025
Emergence of a senescent and inflammatory pulmonary CD4<sup>+</sup> T cell population prior to lung allograft failureSajad Moshkelgosha, Liran Levy, Shahideh Safavi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 23, 2025
The location and degree of residual disease determines recurrence patterns and survival in patients with esophageal adenocarcinoma after trimodal therapyWeston G Andrews, Sandra Blitz, Marisa Sewell, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Engineered mesenchymal stromal cell therapy during human lung <i>ex vivo</i> lung perfusion is compromised by acidic lung microenvironmentAntti I Nykänen, Andrea Mariscal, Allen Duong, et al.
Pageof 7